Cargando…

Comment on Lachin et al. The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes. Diabetes Care 2021;44:2225–2230

Detalles Bibliográficos
Autores principales: Quinn, Lauren M., Thayakaran, Rasiah, Thomas, Neil, Nirantharakumar, Krishnarajah, Narendran, Parth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918199/
https://www.ncbi.nlm.nih.gov/pubmed/35245356
http://dx.doi.org/10.2337/dc21-2372
_version_ 1784668681852157952
author Quinn, Lauren M.
Thayakaran, Rasiah
Thomas, Neil
Nirantharakumar, Krishnarajah
Narendran, Parth
author_facet Quinn, Lauren M.
Thayakaran, Rasiah
Thomas, Neil
Nirantharakumar, Krishnarajah
Narendran, Parth
author_sort Quinn, Lauren M.
collection PubMed
description
format Online
Article
Text
id pubmed-8918199
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-89181992022-03-17 Comment on Lachin et al. The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes. Diabetes Care 2021;44:2225–2230 Quinn, Lauren M. Thayakaran, Rasiah Thomas, Neil Nirantharakumar, Krishnarajah Narendran, Parth Diabetes Care e-Letters: Comments and Responses American Diabetes Association 2022-03 2022-03-04 /pmc/articles/PMC8918199/ /pubmed/35245356 http://dx.doi.org/10.2337/dc21-2372 Text en © 2022 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license.
spellingShingle e-Letters: Comments and Responses
Quinn, Lauren M.
Thayakaran, Rasiah
Thomas, Neil
Nirantharakumar, Krishnarajah
Narendran, Parth
Comment on Lachin et al. The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes. Diabetes Care 2021;44:2225–2230
title Comment on Lachin et al. The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes. Diabetes Care 2021;44:2225–2230
title_full Comment on Lachin et al. The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes. Diabetes Care 2021;44:2225–2230
title_fullStr Comment on Lachin et al. The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes. Diabetes Care 2021;44:2225–2230
title_full_unstemmed Comment on Lachin et al. The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes. Diabetes Care 2021;44:2225–2230
title_short Comment on Lachin et al. The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes. Diabetes Care 2021;44:2225–2230
title_sort comment on lachin et al. the beneficial effects of earlier versus later implementation of intensive therapy in type 1 diabetes. diabetes care 2021;44:2225–2230
topic e-Letters: Comments and Responses
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918199/
https://www.ncbi.nlm.nih.gov/pubmed/35245356
http://dx.doi.org/10.2337/dc21-2372
work_keys_str_mv AT quinnlaurenm commentonlachinetalthebeneficialeffectsofearlierversuslaterimplementationofintensivetherapyintype1diabetesdiabetescare20214422252230
AT thayakaranrasiah commentonlachinetalthebeneficialeffectsofearlierversuslaterimplementationofintensivetherapyintype1diabetesdiabetescare20214422252230
AT thomasneil commentonlachinetalthebeneficialeffectsofearlierversuslaterimplementationofintensivetherapyintype1diabetesdiabetescare20214422252230
AT nirantharakumarkrishnarajah commentonlachinetalthebeneficialeffectsofearlierversuslaterimplementationofintensivetherapyintype1diabetesdiabetescare20214422252230
AT narendranparth commentonlachinetalthebeneficialeffectsofearlierversuslaterimplementationofintensivetherapyintype1diabetesdiabetescare20214422252230